EDUCATING IMMUNE CELLS. ELIMINATING CANCER.
Dead / Abandoned — Abandoned — no statement of use filed (as of 14 Mar 2022)
What this means for you
This application is over — abandoned 14 Mar 2022. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 87953373
- Mark type
- Stylized text
- Filed
- 07 Jun 2018
- Published for opposition
- 11 Dec 2018
- Abandoned
- 14 Mar 2022
- Attorney of record
- Kristen S. Ruisi
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical products and drugs for the treatment of cancerous hematologic and solid tumors
Owner
- Mana Therapeutics, Inc., Bethesda, MD, US
- Mana Therapeutics, Inc., Bethesda, MD, US
Prosecution history
- 14 Mar 2022 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 14 Mar 2022 — ABANDONMENT - NO USE STATEMENT FILED
- 03 Jul 2021 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 02 Jul 2021 — SOU EXTENSION 5 GRANTED
- 24 Jun 2021 — SOU EXTENSION 5 FILED
- 24 Jun 2021 — SOU TEAS EXTENSION RECEIVED
- 28 May 2021 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 28 May 2021 — CORRECTED NOA E-MAILED
- 27 May 2021 — SOU EXTENSION 4 GRANTED
- 02 Feb 2021 — SOU EXTENSION 4 FILED
- 27 May 2021 — DIVISIONAL PROCESSING COMPLETE
- 28 Apr 2021 — DIVISIONAL REQUEST RECEIVED
- 26 May 2021 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 17 Feb 2021 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 02 Feb 2021 — TEAS REQUEST TO DIVIDE RECEIVED